About this trial
Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans have limited access to supervised exercise therapy, a facility-based program proven to improve walking ability in PAD, which is poorly attended due to the inconvenience and cost of attending a 12-week program with multiple weekly sessions. This CDA-2 application will investigate the feasibility of home-based exercise therapy (HBET) delivered using mobile health (mHealth) technologies in Veterans with symptomatic PAD. We will partner with the MOVE! program to deliver HBET through group behavioral coaching and a novel wearable activity monitor in a newly proposed program called Smart MOVE!. There is a clear need to provide effective and convenient alternatives to supervised exercise for Veterans with PAD. This study will provide evidence to proceed with Smart MOVE!, a much-needed patient-centered rehabilitation program for Veterans with PAD.
Eligibility criteria
Qualifiers
Age >40 years
Eligible Veteran status
Clinically stable intermittent claudication ( 2 months of Rutherford Class II symptoms, no evidence of chronic limb-threatening ischemia)
Established PAD diagnosis (abnormal ankle-brachial index or evidence of PAD on prior certified vascular laboratory or radiology imaging)
Disqualifiers
Above or below knee amputation
critical limb ischemia (rest pain or tissue loss including ulceration or gangrene)
inability to walk without a walker
wheelchair confinement
Trial design
Treatments tested in this trial
- Smart MOVE!
- General walking advice
- Performance evaluation
Treatment groups
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
LifeQ
Collaborator